Stocks · News reference
8-K filing — ACHIEVE LIFE SCIENCES, INC. (ACHV)
Filed: 2026-10-01 AccNo: 0001193125-26-410781 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18
Stifel analyst James Condulis initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $18.
Achieve Life Sciences To Present 52-Week Cytisinicline Data For Smoking And Vaping Cessation At CHEST 2026 On October 20